Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers

Hongkwan Cho, Swathi Balaji, Abdul Q. Sheikh, Jennifer R. Hurley, Ye F. Tian, Joel H. Collier, Timothy M. Crombleholme, Daria A. Narmoneva

Research output: Contribution to journalArticle

Abstract

RAD16-II peptide nanofibers are promising for vascular tissue engineering and were shown to enhance angiogenesis in vitro and in vivo, although the mechanism remains unknown. We hypothesized that the pro-angiogenic effect of RAD16-II results from low-affinity integrin-dependent interactions of microvascular endothelial cells (MVECs) with RAD motifs. Mouse MVECs were cultured on RAD16-II with or without integrin and MAPK/ERK pathway inhibitors, and angiogenic responses were quantified. The results were validated in vivo using a mouse diabetic wound healing model with impaired neovascularization. RAD16-II stimulated spontaneous capillary morphogenesis, and increased β 3 integrin phosphorylation and VEGF expression in MVECs. These responses were abrogated in the presence of β 3 and MAPK/ERK pathway inhibitors or on the control peptide without RAD motifs. Wide-spectrum integrin inhibitor echistatin completely abolished RAD16-II-mediated capillary morphogenesis in vitro and neovascularization and VEGF expression in the wound in vivo. The addition of the RGD motif to RAD16-II did not change nanofiber architecture or mechanical properties, but resulted in significant decrease in capillary morphogenesis. Overall, these results suggest that low-affinity non-specific interactions between cells and RAD motifs can trigger angiogenic responses via phosphorylation of β 3 integrin and MAPK/ERK pathway, indicating that low-affinity sequences can be used to functionalize biocompatible materials for the regulation of cell migration and angiogenesis, thus expanding the current pool of available motifs that can be used for such functionalization. Incorporation of RAD or similar motifs into protein engineered or hybrid peptide scaffolds may represent a novel strategy for vascular tissue engineering and will further enhance design opportunities for new scaffold materials.

Original languageEnglish (US)
Pages (from-to)154-164
Number of pages11
JournalActa Biomaterialia
Volume8
Issue number1
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Nanofibers
Endothelial cells
Integrins
Peptides
Phosphorylation
Endothelial Cells
Chemical activation
MAP Kinase Signaling System
Tissue engineering
Injections
Morphogenesis
Tissue Engineering
Vascular Endothelial Growth Factor A
Blood Vessels
Scaffolds (biology)
Biomaterials
Scaffolds
Amino Acid Motifs
Cells
Angiogenesis Inhibitors

Keywords

  • Angiogenesis
  • Low-affinity interactions
  • Self-assembling peptide nanofibers
  • Vascular tissue engineering

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Biomaterials
  • Biomedical Engineering
  • Molecular Biology

Cite this

Cho, H., Balaji, S., Sheikh, A. Q., Hurley, J. R., Tian, Y. F., Collier, J. H., ... Narmoneva, D. A. (2012). Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers. Acta Biomaterialia, 8(1), 154-164. https://doi.org/10.1016/j.actbio.2011.08.029

Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers. / Cho, Hongkwan; Balaji, Swathi; Sheikh, Abdul Q.; Hurley, Jennifer R.; Tian, Ye F.; Collier, Joel H.; Crombleholme, Timothy M.; Narmoneva, Daria A.

In: Acta Biomaterialia, Vol. 8, No. 1, 01.01.2012, p. 154-164.

Research output: Contribution to journalArticle

Cho, H, Balaji, S, Sheikh, AQ, Hurley, JR, Tian, YF, Collier, JH, Crombleholme, TM & Narmoneva, DA 2012, 'Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers', Acta Biomaterialia, vol. 8, no. 1, pp. 154-164. https://doi.org/10.1016/j.actbio.2011.08.029
Cho, Hongkwan ; Balaji, Swathi ; Sheikh, Abdul Q. ; Hurley, Jennifer R. ; Tian, Ye F. ; Collier, Joel H. ; Crombleholme, Timothy M. ; Narmoneva, Daria A. / Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers. In: Acta Biomaterialia. 2012 ; Vol. 8, No. 1. pp. 154-164.
@article{8c08b88d55304e6daaee1292129ca6a1,
title = "Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers",
abstract = "RAD16-II peptide nanofibers are promising for vascular tissue engineering and were shown to enhance angiogenesis in vitro and in vivo, although the mechanism remains unknown. We hypothesized that the pro-angiogenic effect of RAD16-II results from low-affinity integrin-dependent interactions of microvascular endothelial cells (MVECs) with RAD motifs. Mouse MVECs were cultured on RAD16-II with or without integrin and MAPK/ERK pathway inhibitors, and angiogenic responses were quantified. The results were validated in vivo using a mouse diabetic wound healing model with impaired neovascularization. RAD16-II stimulated spontaneous capillary morphogenesis, and increased β 3 integrin phosphorylation and VEGF expression in MVECs. These responses were abrogated in the presence of β 3 and MAPK/ERK pathway inhibitors or on the control peptide without RAD motifs. Wide-spectrum integrin inhibitor echistatin completely abolished RAD16-II-mediated capillary morphogenesis in vitro and neovascularization and VEGF expression in the wound in vivo. The addition of the RGD motif to RAD16-II did not change nanofiber architecture or mechanical properties, but resulted in significant decrease in capillary morphogenesis. Overall, these results suggest that low-affinity non-specific interactions between cells and RAD motifs can trigger angiogenic responses via phosphorylation of β 3 integrin and MAPK/ERK pathway, indicating that low-affinity sequences can be used to functionalize biocompatible materials for the regulation of cell migration and angiogenesis, thus expanding the current pool of available motifs that can be used for such functionalization. Incorporation of RAD or similar motifs into protein engineered or hybrid peptide scaffolds may represent a novel strategy for vascular tissue engineering and will further enhance design opportunities for new scaffold materials.",
keywords = "Angiogenesis, Low-affinity interactions, Self-assembling peptide nanofibers, Vascular tissue engineering",
author = "Hongkwan Cho and Swathi Balaji and Sheikh, {Abdul Q.} and Hurley, {Jennifer R.} and Tian, {Ye F.} and Collier, {Joel H.} and Crombleholme, {Timothy M.} and Narmoneva, {Daria A.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.actbio.2011.08.029",
language = "English (US)",
volume = "8",
pages = "154--164",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers

AU - Cho, Hongkwan

AU - Balaji, Swathi

AU - Sheikh, Abdul Q.

AU - Hurley, Jennifer R.

AU - Tian, Ye F.

AU - Collier, Joel H.

AU - Crombleholme, Timothy M.

AU - Narmoneva, Daria A.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - RAD16-II peptide nanofibers are promising for vascular tissue engineering and were shown to enhance angiogenesis in vitro and in vivo, although the mechanism remains unknown. We hypothesized that the pro-angiogenic effect of RAD16-II results from low-affinity integrin-dependent interactions of microvascular endothelial cells (MVECs) with RAD motifs. Mouse MVECs were cultured on RAD16-II with or without integrin and MAPK/ERK pathway inhibitors, and angiogenic responses were quantified. The results were validated in vivo using a mouse diabetic wound healing model with impaired neovascularization. RAD16-II stimulated spontaneous capillary morphogenesis, and increased β 3 integrin phosphorylation and VEGF expression in MVECs. These responses were abrogated in the presence of β 3 and MAPK/ERK pathway inhibitors or on the control peptide without RAD motifs. Wide-spectrum integrin inhibitor echistatin completely abolished RAD16-II-mediated capillary morphogenesis in vitro and neovascularization and VEGF expression in the wound in vivo. The addition of the RGD motif to RAD16-II did not change nanofiber architecture or mechanical properties, but resulted in significant decrease in capillary morphogenesis. Overall, these results suggest that low-affinity non-specific interactions between cells and RAD motifs can trigger angiogenic responses via phosphorylation of β 3 integrin and MAPK/ERK pathway, indicating that low-affinity sequences can be used to functionalize biocompatible materials for the regulation of cell migration and angiogenesis, thus expanding the current pool of available motifs that can be used for such functionalization. Incorporation of RAD or similar motifs into protein engineered or hybrid peptide scaffolds may represent a novel strategy for vascular tissue engineering and will further enhance design opportunities for new scaffold materials.

AB - RAD16-II peptide nanofibers are promising for vascular tissue engineering and were shown to enhance angiogenesis in vitro and in vivo, although the mechanism remains unknown. We hypothesized that the pro-angiogenic effect of RAD16-II results from low-affinity integrin-dependent interactions of microvascular endothelial cells (MVECs) with RAD motifs. Mouse MVECs were cultured on RAD16-II with or without integrin and MAPK/ERK pathway inhibitors, and angiogenic responses were quantified. The results were validated in vivo using a mouse diabetic wound healing model with impaired neovascularization. RAD16-II stimulated spontaneous capillary morphogenesis, and increased β 3 integrin phosphorylation and VEGF expression in MVECs. These responses were abrogated in the presence of β 3 and MAPK/ERK pathway inhibitors or on the control peptide without RAD motifs. Wide-spectrum integrin inhibitor echistatin completely abolished RAD16-II-mediated capillary morphogenesis in vitro and neovascularization and VEGF expression in the wound in vivo. The addition of the RGD motif to RAD16-II did not change nanofiber architecture or mechanical properties, but resulted in significant decrease in capillary morphogenesis. Overall, these results suggest that low-affinity non-specific interactions between cells and RAD motifs can trigger angiogenic responses via phosphorylation of β 3 integrin and MAPK/ERK pathway, indicating that low-affinity sequences can be used to functionalize biocompatible materials for the regulation of cell migration and angiogenesis, thus expanding the current pool of available motifs that can be used for such functionalization. Incorporation of RAD or similar motifs into protein engineered or hybrid peptide scaffolds may represent a novel strategy for vascular tissue engineering and will further enhance design opportunities for new scaffold materials.

KW - Angiogenesis

KW - Low-affinity interactions

KW - Self-assembling peptide nanofibers

KW - Vascular tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84855954013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855954013&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2011.08.029

DO - 10.1016/j.actbio.2011.08.029

M3 - Article

VL - 8

SP - 154

EP - 164

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

IS - 1

ER -